Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wasmuth

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine|May 12, 2015
Pulmonary hypertension in HIV infection: a prospective echocardiographic studyC Schwarze-Zander, S Pabst, C Hammerstingl, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Epidemiology and Infection|March 18, 2021
Rabies post-exposure prophylaxis in Germany - What are the challenges?P Meyerhoff, S Manekeller, N Saleh, et al.
AIDS (London, England)|November 25, 2011
Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patientsChristoph Wyen, Björn Jensen, Marcus Hentrich, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
Infection|October 2, 2013
Causes of death in HIV-infected patients from the Cologne-Bonn cohortK Ehren, C Hertenstein, T Kümmerle, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine|May 12, 2015
Pulmonary hypertension in HIV infection: a prospective echocardiographic studyC Schwarze-Zander, S Pabst, C Hammerstingl, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Epidemiology and Infection|March 18, 2021
Rabies post-exposure prophylaxis in Germany - What are the challenges?P Meyerhoff, S Manekeller, N Saleh, et al.
AIDS (London, England)|November 25, 2011
Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patientsChristoph Wyen, Björn Jensen, Marcus Hentrich, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
Infection|October 2, 2013
Causes of death in HIV-infected patients from the Cologne-Bonn cohortK Ehren, C Hertenstein, T Kümmerle, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Pageof 6